Dr. David Steiner, M.D.
What this data tells you about Dr. Steiner
Dr. David Steiner is a cardiovascular disease in Hollywood, FL, with 19 years in practice. Based on federal Medicare data, Dr. Steiner performed 6,686 Medicare services across 4,366 unique beneficiaries.
Between the years covered by Open Payments, Dr. Steiner received a total of $11,035 from 44 pharmaceutical and/or device companies across 289 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Steiner is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 1,080 | $19 | $50 |
| Office visit, established patient (30-39 min) | 753 | $93 | $334 |
| Electrocardiogram (EKG), 12-lead | 520 | $11 | $38 |
| Office visit, established patient, complex (40-54 min) | 446 | $126 | $474 |
| EKG interpretation and report | 429 | $7 | $11 |
| Urinalysis, manual | 402 | $3 | $10 |
| Echocardiogram, transthoracic | 395 | $147 | $518 |
| Regadenoson injection (Lexiscan) for heart stress test | 320 | $41 | $132 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 294 | $302 | $404 |
| Advance care planning consultation, first 30 min | 255 | $81 | $222 |
| Annual wellness visit, follow-up | 247 | $131 | $340 |
| Annual depression screening | 234 | $19 | $48 |
| Blood draw (venipuncture) | 186 | $8 | $10 |
| Hospital follow-up visit, moderate complexity | 149 | $65 | $186 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 148 | $344 | $1,174 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 148 | $49 | $185 |
| Office visit, established patient (20-29 min) | 89 | $62 | $238 |
| Urine microalbumin (protein) analysis | 81 | $6 | $30 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 56 | $137 | $497 |
| New patient office visit, complex (60-74 min) | 46 | $149 | $585 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 44 | $95 | $316 |
| Transitional care management services for problem of high complexity | 44 | $221 | $723 |
| Ultrasound of both sides of head and neck blood flow | 42 | $147 | $507 |
| Initial hospital admission, high complexity | 42 | $139 | $518 |
| Drug injection, under skin or into muscle | 40 | $9 | $38 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 28 | $168 | $437 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 26 | $51 | $196 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 25 | $21 | $68 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 25 | $660 | $2,290 |
| Chest X-ray, 2 views | 23 | $16 | $89 |
| Transitional care management services for problem of at least moderate complexity | 22 | $165 | $537 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 17 | $58 | $199 |
| Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | 16 | $875 | $2,973 |
| Ultrasound of leg arteries or artery grafts | 14 | $171 | $640 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (77%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Steiner is a clinical cardiology specialist, with above-average Medicare volume (top 14% in FL), and low-engagement industry engagement, with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Steiner experienced with denosumab injection (prolia/xgeva)?
Does Dr. Steiner receive payments from pharmaceutical companies?
How do Dr. Steiner's costs compare to other cardiovascular diseases in Hollywood?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology